News

Pharmabiz27m
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drug ...
Pharmabiz27m
Telangana DCA's arrests of wholesalers for spurious drugs trigger nationwide call for stronger enforcement
Telangana DCA's arrests of wholesalers for spurious drugs trigger nationwide call for stronger enforcement: Peethaambaran Kunnathoor, Chennai Monday, June 30, 2025, 08:00 Hrs [IST ...
Pharmabiz27m
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain: Shardul Nautiyal, Mumbai Monday, June 30, 2025, 08:00 Hrs [IST] The Pharmaceuti ...
Pharmabiz27m
DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules
DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drugs Consultative Commi ...
Pharmabiz27m
DCGI responds on clarifications sought by Pharmexcil on export NOC guidance document
DCGI responds on clarifications sought by Pharmexcil on export NOC guidance document: Shardul Nautiyal, Mumbai Monday, June 30, 2025, 08:00 Hrs [IST] In order to ensure smooth imp ...
Pharmabiz1d
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis: United Kingdom Saturday, June 28, 2025, 15:00 Hrs [IST] Biodexa Pha ...
Pharmabiz1d
KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada
KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada: Cambridge, Massachusetts Saturday, June 28, 2025, 14:00 Hrs [IST] KalVist ...
Pharmabiz1d
Icon Group and Varian expand partnership to deliver advanced cancer technology across the United Kingdom
Icon Group and Varian expand partnership to deliver advanced cancer technology across the United Kingdom: London Saturday, June 28, 2025, 16:00 Hrs [IST] Icon Group, a global lead ...
Pharmabiz1d
Applied StemCell releases hiEX Research iPSC Exosomes to explore next-generation regenerative medicine research
Applied StemCell releases hiEX Research iPSC Exosomes to explore next-generation regenerative medicine research: Milpitas, California Saturday, June 28, 2025, 17:00 Hrs [IST] Appl ...
Pharmabiz1d
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma: Princeton, New Jersey Saturday, June 28, 20 ...
Pharmabiz1d
WHO issues alert on the use of semaglutide medicines and risk of non-arteritic anterior ischemic optic neuropathy
WHO is alerting health-care professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicines—Ozempic, ...
Pharmabiz1d
European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME
European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME: Berlin Saturday, June 28, 2025, 09:00 Hrs [IST] The Eur ...